Posted by Michael Wonder on 27 May 2019
NHS England wants money back guarantee on Orkambi
24 May 2019 - Vertex resisting real-world data proposal.
NHS England and Vertex are both claiming to have made significant new concessions in order to break the deadlock over cystic fibrosis drug Orkambi – but a deal remains out of reach.
Vertex has been locked in a row with England’s cost effectiveness watchdog NICE and specialist medicines budget holder NHS England for more than three years, and today both sides disclosed details of their continuing negotiations.
NHS England has revealed that it wants to use a kind of money back guarantee via a two year managed access programme – but Vertex looks to be holding out for a no strings attached deal.
